Want to see COO full AI Analyst Report?
COO Stock Chart & Stats
$72.68
$0.08(0.11%)
At close: 4:00 PM EDT
$72.68
$0.08(0.11%)
Day’s Range― - ―
52-Week Range$58.89 - $89.83
Previous Close$70.4
Volume1.47M
Average Volume (3M)1.76M
Market Cap
$13.51B
Enterprise Value$14.59K
Total Cash (Recent Filing)$138.80M
Total Debt (Recent Filing)$2.46B
Price to Earnings (P/E)59.1
Beta0.55
Next Earnings
Sep 09, 2026EPS Estimate
1.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.18
Shares Outstanding195,030,620
10 Day Avg. Volume1,473,068
30 Day Avg. Volume1,758,220
Financial Highlights & Ratios
PEG Ratio-8.14
Price to Book (P/B)1.70
Price to Sales (P/S)3.42
P/FCF Ratio32.24
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$79.25Price Target Upside9.04% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
EPS Forecast (FY)4.63
Revenue Forecast (FY)$4.31B
Bulls Say, Bears Say
Bulls Say
Steady Revenue Growth And Market LeadershipConsistent multi-year growth and leading contact-lens share support durable scale advantages, customer reach and product adoption. These factors can reinforce pricing power and provide a stable foundation for continued expansion.
Innovation And Product MomentumGrowth in myopia control, daily lenses and fertility products indicates meaningful innovation across both divisions. Expanding clinical and consumer adoption can strengthen the portfolio and support structurally higher demand.
Moderate Leverage And Cash Generation TargetsA large equity base and moderate leverage provide financial flexibility for investment and capital allocation. Management’s multi-year cash-flow targets, if achieved, could improve resilience and fund growth initiatives.
Bears Say
Recent Margin And Earnings PressureThe decline in profitability despite continued revenue growth signals weaker earnings conversion. FX, tariffs, inventory actions and lower production could keep margins below historical levels and limit operating leverage.
Litigation-Related Cash OutflowsThe settlement creates a substantial cash obligation and reduces near-term financial flexibility. Although largely quantified, concentrated payments can weigh on reported earnings, free cash flow and capital allocation.
Asia-Pacific WeaknessWeak demand and legacy-product rationalization in major APAC markets can pressure regional growth for several periods. Prolonged softness may dilute company-wide expansion and raise execution demands for portfolio renewal.
Cooper Co News
COO FAQ
What was Cooper Co’s price range in the past 12 months?
Cooper Co lowest stock price was $58.89 and its highest was $89.83 in the past 12 months.
What is Cooper Co’s market cap?
Cooper Co’s market cap is $13.51B.
When is Cooper Co’s upcoming earnings report date?
Cooper Co’s upcoming earnings report date is Sep 09, 2026 which is in 6 days.
How were Cooper Co’s earnings last quarter?
Cooper Co released its earnings results on Jun 04, 2026. The company reported $1.21 earnings per share for the quarter, beating the consensus estimate of $1.104 by $0.106.
Is Cooper Co overvalued?
According to Wall Street analysts Cooper Co’s price is currently Undervalued.
Does Cooper Co pay dividends?
Cooper Co pays a Semiannually dividend of $0.007 which represents an annual dividend yield of N/A. See more information on Cooper Co dividends here
What is Cooper Co’s EPS estimate?
Cooper Co’s EPS estimate is 1.12.
How many shares outstanding does Cooper Co have?
Cooper Co has 195,030,620 shares outstanding.
What happened to Cooper Co’s price movement after its last earnings report?
Cooper Co reported an EPS of $1.21 in its last earnings report, beating expectations of $1.104. Following the earnings report the stock price went up 8.578%.
Which hedge fund is a major shareholder of Cooper Co?
Currently, no hedge funds are holding shares in COO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cooper Co Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$79.25 (9.04% Upside)
$79.25 (9.04% Upside)
Blogger Sentiment
Bullish
COO Sentiment 67%
Sector Average 60%
Sector Average 60%
Hedge Fund Trend
Increased
By 2.5M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 2.4%
Last 30 Days ▲ 6.3%
Last 30 Days ▲ 6.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
6.73%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
0.55%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Cooper Co
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
COO Company Deck
COO Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a generally positive operational and financial picture: record quarterly revenue and strong non-GAAP EPS, meaningful margin expansion, robust product-level growth (notably MiSight and CooperSurgical fertility), improved free cash flow and active strategic initiatives. However, material near-term headwinds create caution — a significant litigation settlement affecting GAAP results and concentrated cash outflows, Asia Pacific market softness tied to legacy product rationalization and consumer weakness (especially Japan/China), and expected short-term gross margin pressure from FX, tariffs and inventory optimization. Management balanced conservative guidance with a clear plan for capital allocation and strategic review progress, leaving the near-term outlook mixed but supported by strong execution and long-term cash-generation targets.View all COO earnings summariesCOO Net sales Breakdown
67.05% CooperVision
32.95% CooperSurgical
COO Stock 12 Month Forecast
Average Price Target
$79.25
▲(9.04% Upside)
Technical Analysis
Baxter International
―
Merit Medical Systems
―
Staar Surgical
―
Teleflex
―
Bausch + Lomb Corporation
―
Ownership Overview
0.60% Insiders
35.18% Mutual Funds
34.54% Other Institutional Investors
1.77% Public Companies and
Individual Investors